Drug
Indapamide clinical trials
- studies test it
- 15
- open now
- 3
- in phase 3
- 2
- first study started
- 2000
Keep track of what changes. Save the Indapamide studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Studies by the year they started
15 studies that test it; most in 2022 (3)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 2
- Phase 3
- 2
- Phase 4
- 8
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 11
Boryung Pharmaceutical Co., Ltd (2) · Qilu Hospital of Shandong University (1) · Hospices Civils de Lyon (1) · Centre for Chronic Disease Control, India (1) · Military Institute od Medicine National Research Institute (1) · West China Hospital (1) · LaborMed Pharma S.A. (1) · Eva M.M. Strijbis (1)
Often tested with
Tested in the same studies.
Perindopril (3) · Amlodipine (3) · Telmisartan (2) · Fimasartan (2) · Hydrochlorothiazide (2) · Lisinopril (1) · Nebivolol (1) · Chlorthalidone (1)
Studies
Open first, then newest update. How each study uses Indapamide is read from its arms, and is right about nine times in ten.
Testing it · 15
- Evaluating the Use of Oral Indapamide to Reduce Disabiltiy Progression in Progressive Multiple Sclerosis (MS)Not yet recruitingPhase 2Eva M.M. StrijbisNCT07765212Written as Indapamide
- Indapamide and Chlorthalidone to Reduce Urine Supersaturation for Kidney Stone PreventionRecruitingPhase 2Insel Gruppe AG, University Hospital BernNCT06111885Written as Indapamide 2.5 MG
- Treatment With Indapamide in Patients With Post-Surgical HypoparathyroidismRecruitingPhase 4Lars RejnmarkNCT07034677Written as Indapamide 1.5 MG SR
- Study of Antihypertensive Treatment and Cardiovascular Risk in Chinese Prehypertensive PopulationCompletedNot applicableQilu Hospital of Shandong UniversityNCT07652567Written as Indapamide
- IDEAL Study: Identification of the Determinants of the Efficacy of Arterial Blood Pressure Lowering DrugsCompletedPhase 4Hospices Civils de LyonNCT00128518Written as Indapamide (T2)
- A Study to Evaluate the Efficacy and Safety of BR1015 Combination TherapyCompletedPhase 3Boryung Pharmaceutical Co., LtdNCT05878561Written as Fimasartan + Indapamide
- Treatment Optimisation for Blood Pressure With Single-Pill Combinations in IndiaCompletedPhase 4Centre for Chronic Disease Control, IndiaNCT05683301Written as Perindopril + Indapamide
- Comparison of Losartan Associated With Indapamide Versus Hyzaar® in the Hypertension TreatmentSuspendedPhase 3EMSNCT01620788Written as Indapamide / Losartan
- Effect of Genetic Polymorphisms of UGT on the PKs of Indapamide in EgyptiansStatus unknownPhase 4Ain Shams UniversityNCT05294484Written as Indapamide 1.5 MG SR
- A Clinical Trial to Evaluate Drug-drug Interactions and Safety Between "BR1015-1" and "BR1015-2" in Healthy VolunteersCompletedPhase 1Boryung Pharmaceutical Co., LtdNCT05097794Written as BR1015-2
- Non-invasive Haemodynamic Assessment in HypertensionCompletedNot applicableMilitary Institute od Medicine National Research InstituteNCT01996085Written as Indapamide/hydrochlorothiazide
- Once-daily Fixed Combination of Three Antihypertensive DrugsStatus unknownPhase 4University of Roma La SapienzaNCT02710539Written as perindopril, indapamide , amlodipine
- Indapamide Versus Hydrochlorothiazide in Elderly Hypertensive Patients With Renal InsufficiencyCompletedPhase 4West China HospitalNCT01172431Written as Indapamide
- A Comparison of Indapamide SR 1.5 mg With HCTZ 25 mg, in Combination With an ACE-inhibitor, in Patients With Mild to Moderate AHT and Type 2 DMCompletedPhase 4LaborMed Pharma S.A.NCT00980187Written as Indapamide
- The Hypertension in the Very Elderly Trial (HYVET)Status unknownPhase 4Imperial College LondonNCT00122811Written as Indapamide SR 1.5mg; Perindopril 2-4mg
Given in every arm · 1 — Indapamide is usual care beside what is tested
As the comparator · 14 — what is tested is compared with Indapamide
- A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-1 and BR1015-2 Under Fed ConditionsNot yet recruitingPhase 1Boryung Pharmaceutical Co., LtdNCT07421388Written as BR1015-2
- A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-3 and BR1015-2 Under Fasting ConditionsNot yet recruitingPhase 1Boryung Pharmaceutical Co., LtdNCT07421401Written as BR1015-2
- A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-1 and BR1015-2 Under Fasting ConditionsNot yet recruitingPhase 1Boryung Pharmaceutical Co., LtdNCT07421375Written as BR1015-2
- A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-3 and BR1015-2 Under Fed ConditionsNot yet recruitingPhase 1Boryung Pharmaceutical Co., LtdNCT07421414Written as BR1015-2
- A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-1 and BR1015-2 Under Fasting ConditionsCompletedPhase 1Boryung Pharmaceutical Co., LtdNCT06744127Written as BR1015-2
- A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-1 and BR1015-2 in Healthy Volunteers Fed ConditionsCompletedPhase 1Boryung Pharmaceutical Co., LtdNCT06744062Written as BR1015-2
- A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-3 and BR1015-2 Under Fasting ConditionsCompletedPhase 1Boryung Pharmaceutical Co., LtdNCT06744426Written as BR1015-2
- A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-3 and BR1015-2 Under Fed ConditionsCompletedPhase 1Boryung Pharmaceutical Co., LtdNCT06744439Written as BR1015-2
- A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fasting Conditions in Healthy VolunteersCompletedPhase 1Boryung Pharmaceutical Co., LtdNCT06008028Written as BR1015-2
- A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy VolunteersCompletedPhase 1Boryung Pharmaceutical Co., LtdNCT06008015Written as BR1015-2
- Efficacy and Safety of Leningrado Association in the Treatment of HypertensionWithdrawnPhase 3EMSNCT03814109Written as Indapamide SR 1.5 MG
- The Comparison Between Spironolactone and Indapamide Monotherapy or in Combination With Amlodipine to Reduce the Risk of Heart FailureStatus unknownPhase 4Shanghai Jiao Tong University School of MedicineNCT04455178Written as Indapamide
- Efficacy and Safety of Leningrado 5 Association in the Treatment of HypertensionWithdrawnPhase 3EMSNCT03814148Written as Natrilix® SR
- Spironolactone Versus Indapamide in Obese and Hypertensive PatientsStatus unknownNot applicablePeking University Third HospitalNCT03626506Written as Indapamide
Codes
What other systems call Indapamide · ClinicalTrials.gg INT007654
- MeSH (NLM) D007190IndapamideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) F089I0511LINDAPAMIDEConfirmed FDA, NLM, Wikidata
- RxNorm 5764Confirmed FDA, Wikidata
- Wikidata Q1078392indapamideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C29119IndapamideOne source FDA
- DrugBank DB00808One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D007190 | Indapamide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | F089I0511L | INDAPAMIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 5764 | — | Confirmed FDA, Wikidata |
| Wikidata | Q1078392 | indapamide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C29119 | Indapamide | One source FDA |
| DrugBank | DB00808 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.